Stocksigma LogoStocksigma Logo

Granules India Reports Strong Q2FY27 Results with 39% YoY PAT Growth

Granules India reported Q2FY27 revenue of INR 15,600 Mn, up 20% YoY (6% QoQ), with EBITDA rising 21% YoY to INR 3,376 Mn (22% margin) and PAT surging 39%

Granules India Reports Strong Q2FY27 Results with 39% YoY PAT Growth

Granules India Ltd 路 Press Release 路 02 Nov 2026, 10:31 pm

Granules India Reports Strong Q2FY27 Results with 39% YoY PAT Growth Granules India reported Q2FY27 revenue of INR 15,600 Mn, up 20% YoY (6% QoQ), with EBITDA rising 21% YoY to INR 3,376 Mn (22% margin) and PAT surging 39% YoY to INR 1,818 Mn. Finished dosages contributed 73% of revenue, followed by API at 13%, PFI at 10%, and Peptides CDMO at 3%. Geographically, North America accounted for 72% and Europe 16%. ROCE stood at 17.6%. Aided by warrant proceeds, net cash reached INR 8,280 Mn versus net debt of INR 1,012 Mn in Q1FY27.

Original exchange filing (PDF)

More announcements from Granules India Ltd

All Granules India Ltd announcements